D-Ribose 2800 mg

Name: D-Ribose 2800 mg
Brand: Nutricost

BrandNutricost→Fiber and Other Nutrients Capsule 6 ingredients 1 caution DSLD #223150

Net contents: 240 Capsule(s)

Target: Adults and Children 4 years and above

DSLD entry: 2020-06-24

2 Ingredients (6)

IngredientGroupSafety

D-RiboseRibose—

Vegetable Capsulescapsule—

Vegetable Magnesium StearateMagnesium stearateUse with Caution

Stearic AcidStearic Acid—

Silicon DioxideSiliconGenerally Safe

Sodium Stearyl FumarateSodium Stearyl Fumarate—

Ingredient amounts require the full DSLD label. View full label at NIH DSLD →

⚠️ Use with caution — restricted in some markets

Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].

3 Safety cross-reference

D-Ribose — Limited Evidence

⚠ May lower blood glucose

⚠ GI discomfort

Magnesium — Use with Caution

⚠ Diarrhea (especially oxide)

⚠ Accumulates in renal impairment

Silicon — Generally Safe

⚠ Very low toxicity

Sodium — Limited Evidence

⚠ Hypertension

⚠ Fluid retention

4 Label claims

• All Other

• Structure/Function

5 Data source

DSLD ID223150

Full labelView at NIH DSLD →

SourceOffice of Dietary Supplements, NIH

Market statusOn market

Entry date2020-06-24

6 More from Nutricost

View Nutricost Safety Scorecard → 47 products

Beta Glucan 1,3/1,6 500 mg Beta Glucan 1,3/1,6 500 mg Unflavored Bone Broth Protein 20 g Unflavored Bone Broth Protein 20 g Vegetable Beef Soup Calcium Citrate 650 mg Unflavored Cranberry 25,000 mg

7 Cite this page

Vancouver

Pkhakadze G. D-Ribose 2800 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 26]. Available from: https://supplement.ge/products/dsld-223150/

CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.

Analyzed by SupplementIndex

PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD

Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG